Asthika Goonewardene
@asthika
#Biotech Analyst. All views expressed are my own, and should not be construed as a buy, hold or sell recommendation on any security.
ID: 24452251
14-03-2009 23:46:58
848 Tweet
1,1K Followers
1,1K Following
Looking forward to a lively discussion at our #Immunooncology panel at #BIO2019. Always fun to be on a panel with Drew Pardoll himself!
Great line up to discuss IO combinations. How do you set yourself up for the next breakthrough in #Cancer #Immunotherapy? Jeff Bockman moderates @CPbyDH Parker Institute for Cancer Immunotherapy GSK Cancer Research Institute Agenus
Cell therapy in the house! And the world's 3rd largest crystal ball. With Neil canavan Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 Travis Young
"People say they want placebo-controlled trials, but I always ask them: 'Would you be willing to die to give a p-value?'" – FDA CDER head Janet Woodcock, on criticism of accelerated approvals (via BioPharma Dive )
Agreed, and well said, Adam Feuerstein ✡️
Learn about pioneering #innovation in #cancer drug development as Asthika Goonewardene leads a conversation with Zachary Hornby Amgen 🧪🔬🧬 Former Account of Eli Lilly and Company Kezar Life Sciences Vertex Ventures #BIOCEO21 bio.org/events/bio-ceo…
#CARTCell Team with CAR T Cellebrity Emily Whitehead w parents Tom and Kari Emily Whitehead Foundation Penn Medicine Penn Medicine - Abramson Cancer Center Cancer Center @ CHOP Children's Hospital
Fun at The Great Academic #celltherapy Debate hosted by Asthika Goonewardene Truist Bank Symposia-cell moderated by Chuck Drake VP Immuno-Oncology JNJInnovative Medicine w/Adrian Hayday King's College London (gammadelta T cells), Michael Caligiuri City of Hope (NK), me Penn Medicine (alphabeta T cells)
📢🥁By popular demand presenting the TOP Oncology publications of 2022. PS: List not exhaustive - so feel free to tag & add important papers to the list OncoAlert NEJM The Lancet Oncology Annals of Oncology Nature Medicine nature Cancer Discovery
ASCO 2025 Annual Meeting #ADCs Recap - Here are the top trials from #ASCO25 with summary. Follow up for more oncology updates: t.ly/7TCD6 #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights | Toni Choueiri, MD | Paolo Tarantino | Sara Tolaney |
ASCO 2025 Annual Meeting #Bispecifics Recap - Here are the top trials from #ASCO25 with summary. Follow up for more oncology updates: t.ly/7TCD6 #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights #ASCO2025 | Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) |